Massimo Varenna (M Varenna)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Randomized Controlled Trial

Bone Mineral Density

Postoperative Pain

Top Venues

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Therapeutic advances in musculoskeletal disease

Calcified tissue international

Rheumatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Massimo Varenna, Francesco Orsini, Raffaele Di Taranto, Francesca Zucchi, Giovanni Adami, Davide Gatti, Chiara Crotti
Bone Turnover Markers and Wnt Signaling Modulators in Early Complex Regional Pain Syndrome. A Pre-specified Observational Study. Calcified tissue international 115 (3) (2024)
Massimo Varenna, Francesco Orsini, Raffaele Di Taranto, Francesca Zucchi, Giovanni Adami, Davide Gatti, Chiara Crotti
Bone Turnover Markers and Wnt Signaling Modulators in Early Complex Regional Pain Syndrome. A Pre-specified Observational Study. Calcified tissue international (2024)
Massimo Varenna, F Orsini, R Di Taranto, F Zucchi, M Manara, R Caporali, C Crotti
How the COVID-19 pandemic affected bone health: a retrospective, longitudinal study on denosumab persistence from the epicentre of European spreading. Archives of osteoporosis 18 (1) (2023)
C Crotti, F Zucchi, C Alfieri, R Caporali, Massimo Varenna
Long-term use of burosumab for the treatment of tumor-induced osteomalacia. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2022)
C Crotti, F Zucchi, C Alfieri, R Caporali, Massimo Varenna
Reply to: appropriate dosing of burosumab in tumor-induced osteomalacia. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2022)
Massimo Varenna, Davide Gatti, Francesca Zucchi, Chiara Crotti, Vania Braga, Giovanni Iolascon, Bruno Frediani, Fabrizio Nannipieri, Maurizio Rossini
Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study. Therapeutic advances in musculoskeletal disease 14 (2022)
Massimo Varenna, Davide Gatti, Francesca Zucchi, Chiara Crotti, Vania Braga, Giovanni Iolascon, Bruno Frediani, Fabrizio Nannipieri, Maurizio Rossini
Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study. Therapeutic advances in musculoskeletal disease 14 (2022)
Massimo Varenna, Vania Braga, Davide Gatti, Giovanni Iolascon, Bruno Frediani, Francesca Zucchi, Chiara Crotti, Fabrizio Nannipieri, Maurizio Rossini
Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study. Therapeutic advances in musculoskeletal disease 13 (2021)
Massimo Varenna, C Crotti, M T Bonati, F Zucchi, M Gallazzi, R Caporali
A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2021)
Massimo Varenna, F Zucchi, C Crotti, M Manara, R Caporali
Decreasing severity of Paget's disease of bone in northern Italy over the last two decades: results of a monocentric study on 391 patients. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 32 (9) (2021)
Massimo Varenna, Chiara Crotti
Bisphosphonates in the treatment of complex regional pain syndrome: is bone the main player at early stage of the disease? Rheumatology international 38 (11) (2018)